JP2022544307A5 - - Google Patents
Info
- Publication number
- JP2022544307A5 JP2022544307A5 JP2022509039A JP2022509039A JP2022544307A5 JP 2022544307 A5 JP2022544307 A5 JP 2022544307A5 JP 2022509039 A JP2022509039 A JP 2022509039A JP 2022509039 A JP2022509039 A JP 2022509039A JP 2022544307 A5 JP2022544307 A5 JP 2022544307A5
- Authority
- JP
- Japan
- Prior art keywords
- lrp6
- antibody
- cdr
- sequence
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962886918P | 2019-08-14 | 2019-08-14 | |
| US62/886,918 | 2019-08-14 | ||
| PCT/CA2020/051120 WO2021026666A1 (en) | 2019-08-14 | 2020-08-14 | Antibodies that bind to lrp6 proteins and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022544307A JP2022544307A (ja) | 2022-10-17 |
| JP2022544307A5 true JP2022544307A5 (enExample) | 2023-08-21 |
Family
ID=74569270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509039A Pending JP2022544307A (ja) | 2019-08-14 | 2020-08-14 | Ｌｒｐ６タンパク質に結合する抗体および使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12583919B2 (enExample) |
| EP (1) | EP4013790A4 (enExample) |
| JP (1) | JP2022544307A (enExample) |
| CN (2) | CN118909117A (enExample) |
| AU (1) | AU2020331424A1 (enExample) |
| CA (1) | CA3147832A1 (enExample) |
| WO (1) | WO2021026666A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7377288B2 (ja) * | 2019-06-11 | 2023-11-09 | アントレラ セラピューティクス インコーポレイテッド | 多価ｆｚｄおよびｗｎｔ結合分子とその使用 |
| CN116200494B (zh) * | 2022-12-30 | 2026-02-24 | 南方医科大学深圳医院 | Ythdf3在制备诊断和治疗宫颈癌产品中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| BRPI0820327A2 (pt) * | 2007-11-02 | 2020-10-06 | Novartis Ag | moléculas e métodos para modulação de proteína relacionada ao receptor de lipoproteína de baixa densidade 6 (lrp6) |
| PH12012502193A1 (en) | 2010-05-06 | 2021-08-09 | Novartis Ag | Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies |
| EP2566892B1 (en) * | 2010-05-06 | 2017-12-20 | Novartis AG | Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (lrp6) antibodies |
| WO2013126911A1 (en) * | 2012-02-24 | 2013-08-29 | Mount Sinai School Of Medicine | Inhibitors and agonists of the low density lipoprotein receptor related domain of lrp6 and/or lrp5 and uses thereof |
| UA122079C2 (uk) * | 2015-12-04 | 2020-09-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Поліпептид, що специфічно зв'язується з lrp5 і lrp6 |
| AU2017272875B2 (en) * | 2016-06-03 | 2023-10-19 | Invectys | Anti HLA-G specific antibodies |
| EP3700930A1 (en) * | 2017-10-25 | 2020-09-02 | The Regents of the University of California | Antibodies against cdcp1 for the treatment and detection of cancer |
| CN111699003B (zh) * | 2017-12-19 | 2024-05-03 | 瑟罗泽恩奥普瑞汀公司 | 抗lrp5/6抗体和使用方法 |
| JP7550647B2 (ja) | 2018-02-14 | 2024-09-20 | アントレラ セラピューティクス インコーポレイテッド | Ｗｎｔシグナル伝達を活性化する多価結合分子およびその使用 |
-
2020
- 2020-08-14 CN CN202411049665.1A patent/CN118909117A/zh active Pending
- 2020-08-14 AU AU2020331424A patent/AU2020331424A1/en active Pending
- 2020-08-14 JP JP2022509039A patent/JP2022544307A/ja active Pending
- 2020-08-14 CN CN202080071918.9A patent/CN114981304B/zh active Active
- 2020-08-14 CA CA3147832A patent/CA3147832A1/en active Pending
- 2020-08-14 US US17/634,916 patent/US12583919B2/en active Active
- 2020-08-14 EP EP20851600.5A patent/EP4013790A4/en active Pending
- 2020-08-14 WO PCT/CA2020/051120 patent/WO2021026666A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022515318A5 (enExample) | ||
| JP2020510422A5 (enExample) | ||
| JP2026041845A5 (enExample) | ||
| JP2017519759A5 (enExample) | ||
| JP2021503455A5 (enExample) | ||
| HRP20190605T1 (hr) | Protutijela anti-fxi i postupci njihove uporabe | |
| RU2018124319A (ru) | Новые антитела к клаудину и способы их применения | |
| JP2024538669A5 (enExample) | ||
| JP2022544308A5 (enExample) | ||
| JP2024153733A5 (enExample) | ||
| JP2022514734A5 (enExample) | ||
| JP2007515165A5 (enExample) | ||
| JP2017521054A5 (enExample) | ||
| IL276675B2 (en) | Anti-PD-1 antibodies and uses thereof | |
| JP2024536881A5 (enExample) | ||
| JP2024001073A5 (enExample) | ||
| JP2025507817A5 (enExample) | ||
| JP2023528416A5 (enExample) | ||
| JP2022544307A5 (enExample) | ||
| JP2023517754A5 (enExample) | ||
| JP2023517754A (ja) | 抗ｍｕｃ１－ｓｅａ抗体 | |
| JP2024532836A5 (enExample) | ||
| JP2024517953A5 (enExample) | ||
| JP2024525916A5 (enExample) | ||
| JP2022513729A5 (enExample) |